Purple AI Appoints Harvard Medical School Professor Goldstein as Scientific Advisory Board Member

Goldstein Joshua N., Professor of Emergency Medicine at Harvard Medical School and Director of the Neurocritical Care Center at Massachusetts General Hospital. Provided by PurpleAI

Purple AI, a company specializing in AI for brain diseases, announced on February 20 that it has appointed Dr. Joshua N. Goldstein as a scientific advisory board member. Dr. Goldstein is expected to provide high-level scientific and clinical advice on the direction of Purple AI's AI research in the fields of stroke and neurocritical care.

Dr. Goldstein is a Professor of Emergency Medicine at Harvard Medical School, Vice Chair of Emergency Medicine at Mass General Brigham, and Director of the Center for Neurologic Emergencies at Massachusetts General Hospital. He is regarded as a leading authority in neuro-emergency medicine who has pioneered research on early risk stratification and prognosis assessment in acute stroke and intracerebral hemorrhage.

Purple AI expects that this advisory agreement will serve as a bridgehead for securing clinical credibility for entry into the U.S. market and for expanding its global business. The company plans to gradually strengthen key elements for entering the U.S. market, including: refining research design to reflect the U.S. clinical environment; advancing data validation systems to meet international regulatory standards; and expanding its collaboration base with major medical institutions in North America.

Building on its selection in 2025 for the Deep Tech TIPS program by the Ministry of SMEs and Startups, Purple AI is expanding the development of an end-to-end AI platform that includes diagnosis and prognosis prediction for stroke (intracerebral hemorrhage and cerebral infarction). In addition, its AI solution for intracerebral hemorrhage diagnosis, which has already received U.S. FDA clearance, is undergoing clinical validation at major general hospitals in North America, including UMass Memorial Health and White Rock Medical Center.

Dr. Goldstein stated, "I look forward to working with Purple AI to strengthen the scientific foundation for improving early diagnosis and treatment management of patients with stroke and intracerebral hemorrhage."

This content was produced with the assistance of AI translation services.